Anti-abortion groups furious as FDA approves generic abortion pill | US news

The movement that left anti-abortion defenders, the US sanitary supervision of the US products and medicines (FDA) quietly approved the request for the production of a new abortion tablet in the beginning of this week.

Thanks to the statement, a company called Evita Solutions will be able to make its common version of Mifepristone, one of two drugs usually used in most US drug abortions. The general version of Mifepristone, which was first approved as a branded drug in 2000, is already available on the market.

Nevertheless ROE V WADE Pressure on the federal government to curb access to the microdistan. Robert F. Kennedy -Jr., Minister of Health, announced last month that his department would consider the safety of Mifepristone.

“FDA promised to overview the safety in the field of chemical abortion, but instead they just lit it in a new version for distribution,” Josh Hawley, a republican senator from Missouri and an abortion, published in X., placed confidence in the leadership in FDA. “

Krustan Hawkins, president of powerful students of the group to combat abortion for the whole life of America, called the approval of “true failure.”

“This is a spot on Trump's presidency,” she added in a statement.

To support their attack on Mifepriston, recently activists against abortion captured in the April newspaper Within the framework of the Ethics and State Policy Center, the Right Thinktank, claiming that almost 11% of women experience sepsis or other serious complications within 45 days after the adoption of mifeperiston. In his letter announcing the MifePristone review, Kennedy quoted the Center’s newspaper.

But this article was not reviewed and not published in a medical journal, and Experts discovered multiple shortcomings In it. For example, this is considered an ectopic pregnancy – in which the embryo implants are somewhere outside the lining of the uterus – as a serious complication. Mifepriston does not cause and does not cause a deterioration in an ectopic pregnancy.

Meanwhile, more than 100 studies conducted for more than three decades and dozen countries came to the conclusion that Mifepriston – a safe and effective tool To put an end to pregnancy.

Supporters of abortion rights celebrated the news about the approval of FDA, saying that this is a victory in relation to the medicine for evidence.

“Expanding the general options, the agency strengthens the impeccable recording of Mifepristone security,” said Kiki Friedman, co-founder and general director of the Hey Jane telemedicine television.

“At a time when politically motivated attacks threaten to undermine science and limit care, it is very important to emphasize that science cannot be clearer.”

The Department of Health did not immediately respond to a request about the comments. However, the representative of the department said The New York Times In the statement that “FDA has a very limited discretion when deciding on whether the general drug should be approved.”

“According to the law, the secretary Health And social services must approve the statement if it demonstrates that Generic is identical to the corporate drug, ”said the representative.

Leave a Comment